84 related articles for article (PubMed ID: 121266)
1. [In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen].
Borgna JL; Rochefort H
C R Seances Acad Sci D; 1979 Dec; 289(15):1141-4. PubMed ID: 121266
[TBL] [Abstract][Full Text] [Related]
2. Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues.
Borgna JL; Rochefort H
J Biol Chem; 1981 Jan; 256(2):859-68. PubMed ID: 7451477
[TBL] [Abstract][Full Text] [Related]
3. Differential binding of antiestrogens by rat uterine and chick oviduct cytosol.
Sutherland RL; Foo MS
Biochem Biophys Res Commun; 1979 Nov; 91(1):183-91. PubMed ID: 518621
[No Abstract] [Full Text] [Related]
4. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
Gulino A; Pasqualini JR
Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular mechanism of action of antiestrogens.
Rochefort H; Borgna JL; Evans E
J Steroid Biochem; 1983 Jul; 19(1A):69-74. PubMed ID: 6887874
[TBL] [Abstract][Full Text] [Related]
6. Species-specific pharmacology of antiestrogens: role of metabolism.
Jordan VC; Robinson SP
Fed Proc; 1987 Apr; 46(5):1870-4. PubMed ID: 3556610
[TBL] [Abstract][Full Text] [Related]
7. Monohydroxytamoxifen: an antioestrogen with high affinity for the chick oviduct oestrogen receptor.
Binart N; Catelli MG; Geynet C; Puri V; Hähnel R; Mester J; Baulieu EE
Biochem Biophys Res Commun; 1979 Dec; 91(3):812-8. PubMed ID: 526285
[No Abstract] [Full Text] [Related]
8. Tamoxifen aziridines: effective inactivators of the estrogen receptor.
Robertson DW; Wei LL; Hayes JR; Carlson KE; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 1981 Oct; 109(4):1298-300. PubMed ID: 7285873
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of tamoxifen and its uterotrophic activity.
Lyman SD; Jordan VC
Biochem Pharmacol; 1985 Aug; 34(15):2787-94. PubMed ID: 4015715
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
Coezy E; Borgna JL; Rochefort H
Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
[TBL] [Abstract][Full Text] [Related]
11. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
Borgna JL; Rochefort H
Mol Cell Endocrinol; 1980 Oct; 20(1):71-85. PubMed ID: 7439523
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-receptor binding and biologic activity of tamoxifen and its metabolites.
Wakeling AE; Slater SR
Cancer Treat Rep; 1980; 64(6-7):741-4. PubMed ID: 7427959
[TBL] [Abstract][Full Text] [Related]
13. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
15. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
[TBL] [Abstract][Full Text] [Related]
16. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
Murphy CS; Langan-Fahey SM; McCague R; Jordan VC
Mol Pharmacol; 1990 Nov; 38(5):737-43. PubMed ID: 2233701
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
Bouhoute A; Leclercq G
Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
[TBL] [Abstract][Full Text] [Related]
20. Efficient and highly selective covalent labeling of the estrogen receptor with [3H]tamoxifen aziridine.
Katzenellenbogen JA; Carlson KE; Heiman DF; Robertson DW; Wei LL; Katzenellenbogen BS
J Biol Chem; 1983 Mar; 258(6):3487-95. PubMed ID: 6833211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
